title: Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
authors.forename: C H
authors.initials: CH
authors.lastname: Polman
authors.forename: F
authors.initials: F
authors.lastname: Deisenhammer
authors.forename: G
authors.initials: G
authors.lastname: Giovannoni
authors.forename: J
authors.initials: J
authors.lastname: Killestein
authors.forename: H
authors.initials: H
authors.lastname: Schellekens
mesh_terms: D000906:Antibodies / Q000276:immunology*; D002986:Clinical Trials as Topic / Q000592:standards; D015331:Cohort Studies; D004351:Drug Resistance / Q000276:immunology; D019317:Evidence-Based Medicine / Q000592:standards; D016899:Interferon-beta / Q000037:antagonists & inhibitors* / Q000276:immunology*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology*; D017410:Practice Guidelines as Topic / Q000592:standards; D015203:Reproducibility of Results; D017211:Treatment Failure
chemical_list: D000906:Antibodies; D016899:Interferon-beta